CareDx (CDNA) Common Equity (2013 - 2026)

CareDx has disclosed Common Equity across 14 years of filings, most recently posting $313.5 million for Q1 2026.

• Common Equity for Q1 2026 came in at $313.5 million, down 17.35% year-over-year; the trailing twelve-month figure through Mar 2026 was $313.5 million (down 17.35% YoY), and the FY2025 annual result was $303.1 million, down 19.91% from the prior year.
• Common Equity came in at $313.5 million for Q1 2026 at CareDx, up from $303.1 million in the prior quarter.
• In the past five years, Common Equity ranged from a high of $457.5 million in Q1 2022 to a low of $256.2 million in Q1 2024.
• The 5-year median for Common Equity is $378.4 million (2024), against an average of $356.3 million.
• Across the five-year window, Common Equity plunged 39.35% in 2023 and surged 48.05% in 2025, its largest moves.
• CareDx's Common Equity stood at $430.9 million in 2022, then slumped by 39.35% to $261.3 million in 2023, then soared by 44.81% to $378.4 million in 2024, then fell by 19.91% to $303.1 million in 2025, then grew by 3.44% to $313.5 million in 2026.
• The last three Common Equity figures came in at $313.5 million (Q1 2026), $303.1 million (Q4 2025), and $311.1 million (Q3 2025), per Business Quant data.